Survival data and predictors of functional outcome an average of 15years after the fontan procedure: The pediatric heart network fontan cohort

Congenital Heart Disease

Volumn 10, Issue 1, 2015, Pages E30-E42

  Atz, Andrew M ^a   Zak, Victor ^b   Mahony, Lynn ^d   Uzark, Karen ^e   Shrader, Peter ^b   Gallagher, Dianne ^b   Paridon, Stephen M ^f   Williams, Richard V ^g   Breitbart, Roger E ^c   Colan, Steven D ^c   Kaltman, Jonathan R ^h   Margossian, Renee ^c   Pasquali, Sara K ⁱ   Allen, Kerstin ^b   Lai, Wyman W ^j   Korsin, Rosalind ^j   Marino, Bradley S ^k   Mirarchi, Nicole ^f   Mccrindle, Brian W ^l  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^g UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^h NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

^j Department of Medicine   (United States)

^k CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^l HOSPITAL FOR SICK CHILDREN   (Canada)

more..

Author keywords

Congenital; Fontan procedure; Functional health status; Heart defects; Pediatrics

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; BIOLOGICAL MARKER;

ADULT; ARTICLE; CATHETER; CROSS-SECTIONAL STUDY; FOLLOW UP; FONTAN PROCEDURE; HEALTH CARE ACCESS; HEALTH STATUS; HEART ARRHYTHMIA; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROTEIN LOSING GASTROENTEROPATHY; QUESTIONNAIRE; SHORT FORM 36; SOCIAL STATUS; SURVIVAL; TREATMENT OUTCOME; ADOLESCENT; ADVERSE EFFECTS; BLOOD; CANADA; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; HEALTH CARE DELIVERY; HEART DEFECTS, CONGENITAL; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS; TIME FACTOR; UNITED STATES; YOUNG ADULT;

ADOLESCENT; BIOMARKERS; CANADA; DISEASE-FREE SURVIVAL; FEMALE; FONTAN PROCEDURE; HEALTH SERVICES ACCESSIBILITY; HEALTH STATUS; HEART DEFECTS, CONGENITAL; HEART TRANSPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; NATRIURETIC PEPTIDE, BRAIN; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84922604949     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/chd.12193     Document Type: Article

References (28)

1. Mahle WT, Wernovsky G, Bridges ND, Linton AB, Paridon SM. Impact of early ventricular unloading on exercise performance in preadolescents with single ventricle Fontan physiology. J Am Coll Cardiol. 1999;34 (5):1637-1643.
2. Rosenthal DN, Friedman AH, Kleinman CS, Kopf GS, Rosenfeld LE, Hellenbrand WE. Thromboembolic complications after Fontan operations. Circulation. 1995;92 (9 Suppl.):II287-II293.
3. Hirsch JC, Goldberg C, Bove EL, etal. Fontan operation in the current era: a 15-year single institution experience. Ann Surg. 2008;248 (3):402-410.
4. Rychik J. Protein-losing enteropathy after Fontan operation. Congenit Heart Dis. 2007;2 (5):288-300.
5. Hellstedt LF. Insurability issues facing the adolescent and adult with congenital heart disease. Nurs Clin North Am. 1994;29 (2):331-343.
6. Reid GJ, Irvine MJ, McCrindle BW, etal. Prevalence and correlates of successful transfer from pediatric to adult health care among a cohort of young adults with complex congenital heart defects. Pediatrics. 2004;113 (3, pt 1):e197-e205.
7. Marino BS. Outcomes after the Fontan procedure. Curr Opin Pediatr. 2002;14 (5):620-626.
8. McCrindle BW, Williams RV, Mitchell PD, etal. Relationship of patient and medical characteristics to health status in children and adolescents after the Fontan procedure. Circulation. 2006;113 (8):1123-1129.
9. Anderson PA, Sleeper LA, Mahony L, etal. Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol. 2008;52 (2):85-98.
10. Turner-Bowker DM, Bartley PJ, Ware JE. SF-36 Health Survey & SF Bibliography: Third Edition (1988-2000). Lincoln, RI: QualityMetric Incorporated; 2002.
11. Varni JW, Burwinkle TM, Rapoff MA, Kamps JL, Olson N. The PedsQL in pediatric asthma: reliability and validity of the Pediatric Quality of Life Inventory generic core scales and asthma module. J Behav Med. 2004;27 (3):297-318.
12. Varni JW, Seid M, Knight TS, Uzark K, Szer IS. The PedsQL 4.0 Generic Core Scales: sensitivity, responsiveness, and impact on clinical decision-making. J Behav Med. 2002;25 (2):175-193.
13. Landgraf JM, Abetz L, Ware JE. The CHQ User's Manual. Second Printing. Boston, MA: Health Act; 1999.
14. Goossens E, Stephani I, Hilderson D, etal. Transfer of adolescents with congenital heart disease from pediatric cardiology to adult health care: an analysis of transfer destinations. J Am Coll Cardiol. 2011;57 (23):2368-2374.
15. Khairy P, Fernandes SM, Mayer JE Jr, etal. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008;117 (1):85-92.
16. Diller GP, Giardini A, Dimopoulos K, etal. Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients. Eur Heart J. 2010;31 (24):3073-3083.
17. D'Udekem Y, Iyengar AJ, Cochrane AD, etal. The Fontan procedure: contemporary techniques have improved long-term outcomes. Circulation. 2007;116 (11 Suppl.):I157-I164.
18. Paridon SM, Mitchell PD, Colan SD, etal. A cross-sectional study of exercise performance during the first 2 decades of life after the Fontan operation. J Am Coll Cardiol. 2008;52 (2):99-107.
19. Giardini A, Hager A, Pace NC, Picchio FM. Natural history of exercise capacity after the Fontan operation: a longitudinal study. Ann Thorac Surg. 2008;85 (3):818-821.
20. Trojnarska O, Gwizdala A, Katarzynski S, etal. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease. Cardiol J. 2009;16 (2):133-141.
21. Anderson PA, Breitbart RE, McCrindle BW, etal. The Fontan patient: inconsistencies in medication therapy across seven pediatric heart network centers. Pediatr Cardiol. 2010;31 (8):1219-1228.
22. Atz AM, Travison TG, McCrindle BW, etal. Late status of Fontan patients with persistent surgical fenestration. J Am Coll Cardiol. 2011;57 (24):2437-2443.
23. Gatzoulis MA, Munk MD, Williams WG, Webb GD. Definitive palliation with cavopulmonary or aortopulmonary shunts for adults with single ventricle physiology. Heart. 2000;83 (1):51-57.
24. Moons P, Van DK, De GS, Gewillig M, Budts W. Is the severity of congenital heart disease associated with the quality of life and perceived health of adult patients? Heart. 2005;91 (9):1193-1198.
25. Fekkes M, Kamphuis RP, Ottenkamp J, etal. Health-related quality of life in young adults with minor congenital heart disease. Psychol Health. 2001;16:239-250.
26. Lambert LM, Minich LL, Newburger JW, etal. Parent- vs. child-reported functional health status after the Fontan procedure. Pediatrics. 2009;124 (5):e942-e949.
27. Idorn L, Jensen AS, Juul K, etal. Quality of life and cognitive function in Fontan patients, a population-based study. Int J Cardiol. 2013;168 (4):3230-3235.
28. Fteropoulli T, Stygall J, Cullen S, Deanfield J, Newman SP. Quality of life of adult congenital heart disease patients: a systematic review of the literature. Cardiol Young. 2013;23 (4):473-485.